|Bid||1.1700 x 900|
|Ask||1.1800 x 3200|
|Day's Range||1.1300 - 1.2100|
|52 Week Range||0.1200 - 5.0200|
|PE Ratio (TTM)||-0.25|
|Earnings Date||Jun 15, 2017 - Jun 16, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||60.00|
Immune Pharmaceuticals Inc. announced today that on August 23, 2017, the Company received written notice from the Listing Qualifications Department of The NASDAQ Stock Market LLC that the Company no longer complies with the minimum stockholders' equity requirement under NASDAQ Listing Rule 5550 for continued listing on The NASDAQ Capital Market because the Company's stockholders' equity as reported ...
Immune Pharmaceuticals Inc. provided the following R&D and business update and summary of recent financial highlights.
NEW YORK, NY / ACCESSWIRE / August 24, 2017 / U.S. markets dropped Wednesday after President Trump warned he would shut down the government if he did not receive funding for his border wall. The Dow Jones ...